Active 0 6 0 6 O
serious 7 14 7 14 B-chronic_disease
infections 15 25 15 25 I-chronic_disease
not 26 29 26 29 O
controlled 30 40 30 40 O
by 41 43 41 43 O
antibiotics 44 55 44 55 B-treatment

Age 0 3 56 59 B-age
> 4 5 60 61 O
1 5 6 61 62 B-lower_bound
year 7 11 63 67 I-lower_bound

DSRCT 0 5 68 73 B-cancer
with 6 10 74 78 O
peritoneal 11 21 79 89 B-cancer
involvement 22 33 90 101 I-cancer

For 0 3 102 105 O
tumors 4 10 106 112 B-cancer
other 11 16 113 118 O
than 17 21 119 123 O
DSRCT 22 27 124 129 B-cancer
, 27 28 129 130 O
Burtomab 29 37 131 139 B-treatment
reactivity 38 48 140 150 O
must 49 53 151 155 O
be 54 56 156 158 O
confirmed 57 66 159 168 O
by 67 69 169 171 O
immunohistochemistry 70 90 172 192 O

For 0 3 193 196 O
tumors 4 10 197 203 B-cancer
other 11 16 204 209 O
than 17 21 210 214 O
DSRCT 22 27 215 220 B-cancer
, 27 28 220 221 O
patients 29 37 222 230 O
must 38 42 231 235 O
have 43 47 236 240 O
a 48 49 241 242 O
history 50 57 243 250 O
of 58 60 251 253 O
tumor 61 66 254 259 O
progression 67 78 260 271 O
or 79 81 272 274 O
recurrence 82 92 275 285 O
or 93 95 286 288 O
failure 96 103 289 296 O
to 104 106 297 299 O
achieve 107 114 300 307 O
complete 115 123 308 316 O
response 124 132 317 325 O
with 133 137 326 330 O
standard 138 146 331 339 B-treatment
therapy 147 154 340 347 I-treatment
or 155 157 348 350 O
< 158 159 351 352 O
20 159 161 352 354 B-upper_bound
% 161 162 354 355 I-upper_bound
chance 163 169 356 362 O
of 170 172 363 365 O
long 173 177 366 370 O
term 178 182 371 375 O
disease 183 190 376 383 O
- 190 191 383 384 O
free 191 195 384 388 O
survival 196 204 389 397 O

History 0 7 398 405 O
of 8 10 406 408 O
allergy 11 18 409 416 O
to 19 21 417 419 O
mouse 22 27 420 425 B-allergy_name
proteins 28 36 426 434 I-allergy_name

Minimum 0 7 435 442 O
life 8 12 443 447 B-clinical_variable
expectancy 13 23 448 458 I-clinical_variable
of 24 26 459 461 O
six 27 30 462 465 B-lower_bound
weeks 31 36 466 471 I-lower_bound
as 37 39 472 474 O
determined 40 50 475 485 O
by 51 53 486 488 O
consenting 54 64 489 499 O
professional 65 77 500 512 O

Patients 0 8 513 521 O
may 9 12 522 525 O
receive 13 20 526 533 O
platelet 21 29 534 542 B-treatment
or 30 32 543 545 O
red 33 36 546 549 B-treatment
blood 37 42 550 555 I-treatment
cell 43 47 556 560 I-treatment
transfusions 48 60 561 573 I-treatment
to 61 63 574 576 O
maintain 64 72 577 585 O
hemoglobin 73 83 586 596 B-clinical_variable
and 84 87 597 600 O
platelets 88 97 601 610 B-clinical_variable
at 98 100 611 613 O
clinical 101 109 614 622 B-clinical_variable
appropriate 110 121 623 634 I-clinical_variable
levels 122 128 635 641 I-clinical_variable

Patients 0 8 642 650 O
with 9 13 651 655 O
DSCRT 14 19 656 661 B-cancer
are 20 23 662 665 O
not 24 27 666 669 O
required 28 36 670 678 O
to 37 39 679 681 O
have 40 44 682 686 O
measurable 45 55 687 697 O
or 56 58 698 700 O
evaluable 59 68 701 710 O
disease 69 76 711 718 O

Platelet 0 8 719 727 B-clinical_variable
count 9 14 728 733 I-clinical_variable
should 15 21 734 740 O
be 22 24 741 743 O
> 25 26 744 745 O
50,000 27 33 746 752 B-lower_bound
/ 33 34 752 753 I-lower_bound
ul 34 36 753 755 I-lower_bound
and 37 40 756 759 O
hemoglobin 41 51 760 770 B-clinical_variable
should 52 58 771 777 O
be 59 61 778 780 O
> 62 63 781 782 O
8gm 64 67 783 786 B-lower_bound
/ 67 68 786 787 I-lower_bound
dl 68 70 787 789 I-lower_bound

Pregnancy 0 9 790 799 B-pregnancy
testing 10 17 800 807 O
will 18 22 808 812 O
be 23 25 813 815 O
carried 26 33 816 823 O
out 34 37 824 827 O
within 38 44 828 834 O
two 45 48 835 838 B-upper_bound
weeks 49 54 839 844 I-upper_bound
prior 55 60 845 850 I-upper_bound
to 61 63 851 853 O
administration 64 78 854 868 O
of 79 81 869 871 O
radioiodinated 82 96 872 886 B-treatment
Burtomab 97 105 887 895 I-treatment
in 106 108 896 898 O
females 109 116 899 906 B-gender
of 117 119 907 909 O
childbearing 120 132 910 922 O
age 133 136 923 926 B-age

Pregnant 0 8 927 935 B-pregnancy
women 9 14 936 941 B-gender
and 15 18 942 945 O
women 19 24 946 951 O
who 25 28 952 955 O
are 29 32 956 959 O
breast 33 39 960 966 O
feeding 40 47 967 974 O
are 48 51 975 978 O
excluded 52 60 979 987 O
for 61 64 988 991 O
fear 65 69 992 996 O
of 70 72 997 999 O
danger 73 79 1000 1006 O
to 80 82 1007 1009 O
the 83 86 1010 1013 O
fetus 87 92 1014 1019 O
/ 92 93 1019 1020 O
infant 93 99 1020 1026 O

Prior 0 5 1027 1032 B-treatment
Therapy 6 13 1033 1040 I-treatment
: 13 14 1040 1041 O
At 15 17 1042 1044 O
least 18 23 1045 1050 O
4 24 25 1051 1052 B-lower_bound
weeks 26 31 1053 1058 I-lower_bound
should 32 38 1059 1065 O
have 39 43 1066 1070 O
elapsed 44 51 1071 1078 O
since 52 57 1079 1084 O
any 58 61 1085 1088 O
biologic 62 70 1089 1097 B-treatment
therapy 71 78 1098 1105 I-treatment
, 78 79 1105 1106 O
or 80 82 1107 1109 O
immunotherapy 83 96 1110 1123 B-treatment

Severe 0 6 1124 1130 O
major 7 12 1131 1136 O
organ 13 18 1137 1142 B-chronic_disease
toxicity 19 27 1143 1151 I-chronic_disease
. 27 28 1151 1152 O
Renal 29 34 1153 1158 B-chronic_disease
, 34 35 1158 1159 O
cardiac 36 43 1160 1167 B-chronic_disease
, 43 44 1167 1168 O
hepatic 45 52 1169 1176 B-chronic_disease
, 52 53 1176 1177 O
pulmonary 54 63 1178 1187 B-chronic_disease
, 63 64 1187 1188 O
gastrointestinal 65 81 1189 1205 B-chronic_disease
and 82 85 1206 1209 O
neurologic 86 96 1210 1220 B-chronic_disease
toxicity 97 105 1221 1229 I-chronic_disease
should 106 112 1230 1236 O
all 113 116 1237 1240 O
be 117 119 1241 1243 O
grade 120 125 1244 1249 B-upper_bound
1 126 127 1250 1251 I-upper_bound
or 128 130 1252 1254 O
less 131 135 1255 1259 O
( 136 137 1260 1261 O
per 137 140 1261 1264 O
NCI 141 144 1265 1268 O
CTC 145 148 1269 1272 O
version 149 156 1273 1280 O
3 157 158 1281 1282 O
criteria 159 167 1283 1291 O
) 167 168 1291 1292 O

Stem 0 4 1293 1297 O
cells 5 10 1298 1303 O
: 10 11 1303 1304 O
Patients 12 20 1305 1313 O
must 21 25 1314 1318 O
have 26 30 1319 1323 O
an 31 33 1324 1326 O
autologous 34 44 1327 1337 B-treatment
hematopoietic 45 58 1338 1351 I-treatment
stem 59 63 1352 1356 I-treatment
cell 64 68 1357 1361 I-treatment
product 69 76 1362 1369 O
cryopreserved 77 90 1370 1383 O
and 91 94 1384 1387 O
available 95 104 1388 1397 O
for 105 108 1398 1401 O
re 109 111 1402 1404 O
- 111 112 1404 1405 O
infusion 112 120 1405 1413 O
after 121 126 1414 1419 O
131 127 130 1420 1423 O
I 131 132 1424 1425 O
- 132 133 1425 1426 O
Burtomab 133 141 1426 1434 B-treatment
treatment 142 151 1435 1444 I-treatment

The 0 3 1445 1448 O
minimum 4 11 1449 1456 O
dose 12 16 1457 1461 O
for 17 20 1462 1465 O
hematopoietic 21 34 1466 1479 O
stem 35 39 1480 1484 I-clinical_variable
cells 40 45 1485 1490 I-clinical_variable
is 46 48 1491 1493 O
2 49 50 1494 1495 B-lower_bound
x 51 52 1496 1497 I-lower_bound
106 53 56 1498 1501 I-lower_bound
CD34 57 61 1502 1506 I-lower_bound
+ 61 62 1506 1507 I-lower_bound
cells 63 68 1508 1513 I-lower_bound
/ 68 69 1513 1514 I-lower_bound
kg 69 71 1514 1516 I-lower_bound

Therefore 0 9 1517 1526 O
negative 10 18 1527 1535 B-pregnancy
pregnancy 19 28 1536 1545 I-pregnancy
test 29 33 1546 1550 O
is 34 36 1551 1553 O
required 37 45 1554 1562 O
for 46 49 1563 1566 O
all 50 53 1567 1570 O
women 54 59 1571 1576 B-gender
of 60 62 1577 1579 O
child 63 68 1580 1585 O
- 68 69 1585 1586 O
bearing 69 76 1586 1593 O
age 77 80 1594 1597 B-age
, 80 81 1597 1598 O
and 82 85 1599 1602 O
appropriate 86 97 1603 1614 O
contraception 98 111 1615 1628 O
is 112 114 1629 1631 O
used 115 119 1632 1636 O
during 120 126 1637 1643 O
the 127 130 1644 1647 O
study 131 136 1648 1653 O
period 137 143 1654 1660 O

Three 0 5 1661 1666 O
weeks 6 11 1667 1672 O
should 12 18 1673 1679 O
have 19 23 1680 1684 O
elapsed 24 31 1685 1692 O
since 32 37 1693 1698 O
last 38 42 1699 1703 O
dose 43 47 1704 1708 O
of 48 50 1709 1711 O
chemotherapy 51 63 1712 1724 B-treatment
or 64 66 1725 1727 O
radiotherapy 67 79 1728 1740 B-treatment

able 0 4 1741 1745 O
to 5 7 1746 1748 O
cooperate 8 17 1749 1758 O
with 18 22 1759 1763 O
radiation 23 32 1764 1773 O
safety 33 39 1774 1780 O
restrictions 40 52 1781 1793 O
during 53 59 1794 1800 O
therapy 60 67 1801 1808 B-treatment
period 68 74 1809 1815 O

other 0 5 1816 1821 O
Burtomab 6 14 1822 1830 B-treatment
- 14 15 1830 1831 O
positive 15 23 1831 1839 O
solid 24 29 1840 1845 B-cancer
tumors 30 36 1846 1852 I-cancer
involving 37 46 1853 1862 O
the 47 50 1863 1866 O
peritoneum 51 61 1867 1877 O
( 62 63 1878 1879 O
e.g. 63 67 1879 1883 O
adrenocortical 68 82 1884 1898 B-cancer
carcinoma 83 92 1899 1908 I-cancer
, 92 93 1908 1909 O
Wilm 94 98 1910 1914 B-cancer
's 98 100 1914 1916 I-cancer
tumor 101 106 1917 1922 I-cancer
) 106 107 1922 1923 O

serum 0 5 1924 1929 B-clinical_variable
AST 6 9 1930 1933 I-clinical_variable
, 9 10 1933 1934 O
ALT 10 13 1934 1937 B-clinical_variable
and 14 17 1938 1941 O
alkaline 18 26 1942 1950 B-clinical_variable
phosphatase 27 38 1951 1962 I-clinical_variable
should 39 45 1963 1969 O
be 46 48 1970 1972 O
≤5 49 51 1973 1975 O
x 52 53 1976 1977 I-upper_bound
upper 54 59 1978 1983 I-upper_bound
limit 60 65 1984 1989 I-upper_bound
of 66 68 1990 1992 I-upper_bound
normal 69 75 1993 1999 I-upper_bound
( 76 77 2000 2001 I-upper_bound
ULN 77 80 2001 2004 I-upper_bound
) 80 81 2004 2005 I-upper_bound

serum 0 5 2006 2011 B-clinical_variable
bilirubin 6 15 2012 2021 I-clinical_variable
≤ 16 17 2022 2023 O
3 18 19 2024 2025 B-upper_bound
x 20 21 2026 2027 I-upper_bound
ULN 22 25 2028 2031 I-upper_bound
and 26 29 2032 2035 O
nausea 30 36 2036 2042 O
and 37 40 2043 2046 O
vomiting 41 49 2047 2055 O
should 50 56 2056 2062 O
be 57 59 2063 2065 O
≤ 60 61 2066 2067 O
grade 62 67 2068 2073 B-upper_bound
2 68 69 2074 2075 I-upper_bound

